ASP Isotopes (NASDAQ:ASPI – Get Free Report) is one of 17 public companies in the “Miscellaneous chemical products” industry, but how does it compare to its peers? We will compare ASP Isotopes to similar businesses based on the strength of its dividends, analyst recommendations, valuation, institutional ownership, earnings, risk and profitability.
Profitability
This table compares ASP Isotopes and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| ASP Isotopes | N/A | -116.87% | -90.49% |
| ASP Isotopes Competitors | -21.17% | 0.85% | -7.44% |
Analyst Ratings
This is a summary of current ratings and recommmendations for ASP Isotopes and its peers, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ASP Isotopes | 0 | 0 | 0 | 0 | N/A |
| ASP Isotopes Competitors | 32 | 335 | 313 | 6 | 2.43 |
Insider & Institutional Ownership
1.5% of ASP Isotopes shares are owned by institutional investors. Comparatively, 72.6% of shares of all “Miscellaneous chemical products” companies are owned by institutional investors. 14.1% of shares of all “Miscellaneous chemical products” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Valuation & Earnings
This table compares ASP Isotopes and its peers gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| ASP Isotopes | N/A | -$4.95 million | -2.46 |
| ASP Isotopes Competitors | $1.24 billion | $32.20 million | 12.76 |
ASP Isotopes’ peers have higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
Summary
ASP Isotopes peers beat ASP Isotopes on 8 of the 9 factors compared.
ASP Isotopes Company Profile
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
Receive News & Ratings for ASP Isotopes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASP Isotopes and related companies with MarketBeat.com's FREE daily email newsletter.
